Suppr超能文献

静脉营养对辅助化疗的影响——替加氟注射后5-氟尿嘧啶分布的实验研究(1)

[Effects of intravenous feeding on adjuvant chemotherapy--an experimental study on the distribution of 5-FU after injection of tegafur (1)].

作者信息

Kimoto M, Nagano H, Sano K

出版信息

Gan To Kagaku Ryoho. 1987 Jan;14(1):135-9.

PMID:3099649
Abstract

Forty-eight male Donryu rats inoculated with Sato lung cancer were used to experimentally determine the effects of intravenous feeding on the concentrations of the chemotherapeutic agents FT-207 and 5-FU in the blood, as well as in the liver and tumorigenic tissue. Following FT-207 administration, the blood, tumor and liver tissue levels were lower than in the IVH group (oral administration). The liver 5-FU concentration, at 0.10 +/- 0.02 microgram/g, was significantly higher in the intravenous feeding group than in the p.o. group (0.05 +/- 0.01 micrograms/g). The 5-FU blood concentration rose quickly, reaching 0.051 +/- 0.013 micrograms/ml and 0.035 +/- 0.004 micrograms/ml at 9 and 12 hours, respectively, following treatment. This was significantly higher than in the p.o. group, which showed corresponding levels of 0.031 +/- 0.004 microgram/ml and 0.022 +/- 0.002 microgram/ml, respectively. The increase in the 5-FU level within the tumor was markedly high in the IVH group compared to the p.o. group, and it peaked at 9 hours following administration. The concentration in the IVH group was thus higher than in the p.o. group at any given time. At 24 hours after treatment, the IVH group level was 0.35 +/- 0.09 microgram/g, against 0.27 +/- 0.05 microgram/g in the p.o. group. The blood concentration of 5-FU following intravenous feeding maintained a high value for a long time, and the 5-FU tumor concentration also remained at a high level. The intravenous route was therefore considered to be advantageous for antitumor chemotherapy.

摘要

选用48只接种了佐藤肺癌的雄性唐里大鼠,通过实验来确定静脉内给药对化疗药物FT - 207和5 - FU在血液、肝脏及肿瘤组织中浓度的影响。给予FT - 207后,血液、肿瘤及肝脏组织中的水平低于静脉内高营养组(口服给药)。静脉内高营养组肝脏中5 - FU浓度为0.10±0.02微克/克,显著高于口服给药组(0.05±0.01微克/克)。给药后,5 - FU血药浓度迅速上升,在9小时和12小时分别达到0.051±0.013微克/毫升和0.035±0.004微克/毫升。这显著高于口服给药组,口服给药组在相应时间的浓度分别为0.031±0.004微克/毫升和0.022±0.002微克/毫升。与口服给药组相比,静脉内高营养组肿瘤内5 - FU水平的升高明显更高,且在给药后9小时达到峰值。因此,在任何给定时间,静脉内高营养组的浓度均高于口服给药组。治疗24小时后,静脉内高营养组的水平为0.35±0.09微克/克,而口服给药组为0.27±0.05微克/克。静脉内给药后5 - FU血药浓度长时间维持在较高水平,5 - FU肿瘤浓度也保持在较高水平。因此,静脉给药途径被认为有利于抗肿瘤化疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验